Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Eli Lilly commits $92.5M to Purdue University for pharmaceutical manufacturing scholarships
Layfette Journal and Courier, IN
Fri, 10/28/22 - 10:30 am
Tags:
Eli Lilly, philanthropy, drug manufacturing, Purdue University
Just announced: upcoming late-stage clinical trials in weight loss and diabetes
Clinical Trials Arena
Sun, 10/23/22 - 07:09 pm
Tags:
clinical trials, Eli Lilly, Novo Nordisk, weight loss, diabetes, Ozempic, Wegovey, Mounjaro
A startup plans an IPO to give a shelved Lilly drug another shot
BioPharma Dive
Wed, 10/19/22 - 10:39 am
Tags:
Acrivon Therapeutics, IPOs, Eli Lilly, prexasertib, ovarian cancer, endometrial cancer, bladder cancer, precision medicine
Eli Lilly to buy precision medicine company Akouos for $487M
Medical Marketing and Media
Tue, 10/18/22 - 11:14 am
Tags:
Eli Lilly, Akouos, M&A, hearing loss, precision medicine
Few safe havens surface in another down quarter for biopharma
EP Vantage
Fri, 10/14/22 - 10:03 am
Tags:
biopharma stocks, COVID-19, Eli Lilly, Bristol Myers Squibb, Merck, Daiichi Sankyo, Vertex Pharmaceuticals, Takeda, Neurocrine, Sarepta Therapeutics, Orion, Pfizer, GSK, Roche, Moderna Therapeutics, BeiGene, BioNTech, Novavax, CureVac
Eli Lilly tasks Nimbus with hitting a 'high-value' target for diabetes, obesity
Endpoints
Tue, 10/11/22 - 10:33 am
Tags:
Nimbus, Eli Lilly, diabetes, obesity
The gloom deepens for biopharma stocks
EP Vantage
Mon, 10/10/22 - 06:54 pm
Tags:
biopharma stocks, AbbVie, Alnylam, AstraZeneca, Biogen, CRISPR Therapeutics, Daiichi Sankyo, Eisai, Eli Lilly, GSK, Intellia Therapeutics, Regeneron, Roche, Sanofi, Sarepta Therapeutics
FDA Review: Alnylam, Cytokinetics, Eli Lilly and More
BioSpace
Sun, 10/9/22 - 06:06 pm
Tags:
FDA, Alnylam, Cytokinetics, Eli Lilly, Owlet, Boston Cell Standards, Kiromic Biopharma, Entera Bio, Transcenta Holdings, Kira Pharmaceuticals, Kite Pharma, Poxel, Seneca Therapeutics
Schrödinger, Eli Lilly Strike $425M Small Molecule Deal
BioSpace
Sun, 10/9/22 - 06:02 pm
Tags:
Schrödinger, Eli Lilly, drug development, small molecule drugs
Lilly's tirzepatide slides into FDA fast lane for obesity, turning up heat on Novo Nordisk's Wegovy
Fierce Pharma
Thu, 10/6/22 - 10:59 am
Tags:
Eli Lilly, Novo Nordisk, obesity, FDA, fast track, tirzepatide
A Biotech Breakthrough Means Big Gains for These 2 Stocks
Motley Fool
Wed, 09/28/22 - 11:02 am
Tags:
Eli Lilly, Biogen, Alzheimer's disease, lecanemab, donanemab
Lilly sued for age discrimination
Medical Marketing and Media
Tue, 09/27/22 - 11:57 pm
Tags:
Eli Lilly, legal, EEOC, age discrimination, sales reps
HHS to pay for 60K doses of Eli Lilly's COVID-19 drug following its commercialization
Beckers Hospital Review
Mon, 09/26/22 - 11:29 pm
Tags:
Eli Lilly, COVID-19, bebtelovimab, federal contracts, HHS
Novartis wins on quantity, but Eli Lilly takes the cake on value of new launches: report
Fierce Pharma
Mon, 09/26/22 - 11:04 am
Tags:
Novartis, Eli Lilly, drug launches, Mounjaro
With Lilly's Mounjaro set for stardom, an Alzheimer's win would be 'icing on the cake': analysts
Fierce Pharma
Fri, 09/23/22 - 10:48 am
Tags:
Eli Lilly, type 2 diabetes, obesity, donanemab, Mounjaro, Alzheimer's disease
Lilly’s Retevmo receives FDA approval to treat solid tumours
Pharmaceutical Business Review
Thu, 09/22/22 - 10:13 am
Tags:
Eli Lilly, FDA, Retevmo, solid tumors, metastatic solid tumors
Eli Lilly touts early demand for high-stakes diabetes launch Mounjaro: analysts
Fierce Pharma
Thu, 09/15/22 - 10:34 am
Tags:
Eli Lilly, tirzepatide, Mounjaro, diabetes
AstraZeneca, Eli Lilly and Roche among pharmaceutical companies upgraded for high returns on R&D investments, analysts say
Morningstar
Wed, 09/14/22 - 09:31 am
Tags:
Roche, AstraZeneca, Eli Lilly, R&D, drug pricing
SpringWorks, Eli Lilly and More Release Data Ahead of ESMO
BioSpace
Thu, 09/8/22 - 04:30 pm
Tags:
SpringWorks Therapeutics, nirogacestat, desmoid tumors, Eli Lilly, ESMO
Brace for an end-of-year boost to drug approvals
EP Vantage
Fri, 09/2/22 - 12:14 pm
Tags:
FDA, drug approvals, Alnylam Pharmaceuticals, Apellis Pharmaceuticals, Bristol Myers Squibb, Eli Lilly, Gilead Sciences, Mirati Therapeutics, Moderna Therapeutics, Provention Bio, Roche, TG Therapeutics, Travere Therapeutics

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.